The landscape of dementia prognosis has progressed considerably with the appearance of advanced biomarkers, which include amyloid PET scans, tau imaging, and blood-based tests that will detect Alzheimer's pathology several years in advance of symptoms arise. While these technological developments symbolize impressive progress in comprehending neuro